Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin

Aim: Glucagon-like peptide-1 can reduce both postprandial plasma glucose (PG) and chylomicron (CM) levels in patients with type 2 diabetes. However, there have been no reports regarding the relationship between the postprandial metabolism of PG and CM. Methods: Patients with type 2 diabetes who were...

Descripción completa

Detalles Bibliográficos
Autores principales: Okajima, Fumitaka, Emoto, Naoya, Kato, Katsuhito, Sugihara, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305676/
https://www.ncbi.nlm.nih.gov/pubmed/27397060
http://dx.doi.org/10.5551/jat.32409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5305676/
https://www.ncbi.nlm.nih.gov/pubmed/27397060
http://dx.doi.org/10.5551/jat.32409

Ejemplares similares